What can help a sore joint?

What can you do before office care?

Home care won't change your joint overnight. Shorten the activity that starts the ache. Don't stop all movement without a reason.

Add strength work slowly. Change one part of your routine at a time. You'll see more clearly what helps your soreness.

What can QC Kinetix discuss with you?

QC Kinetix calls its blood- and marrow-based options regenerative treatments. Your medical provider examines the joint before discussing them. The exam won't tell you that every option fits.

The letters in PRP mean platelet-rich plasma. The clinic spins your blood to gather platelets, then places the plasma into your joint. Concentrated PRP has related blood-draw and spinning steps.

Natural pain treatments and joint preservation are wider clinic terms. Ask which procedure those names mean for you. Knee or hip surgery alternatives are choices to discuss, not promised results.

How strong is the research?

Research on these joint procedures gives mixed results. One large knee study compared three cell-based choices with a steroid shot. After twelve months, none eased pain better than the others.

That study doesn't prove the same result for shoulders. It also can't settle every blood or marrow preparation. Ask whether the research matches your joint and proposed care.

How will you know care helped?

Choose one daily task that matters to you. You might track walking time or sleep. Don't rely on a general promise.

Record how far you can walk before care. Check the same task again later. You can't judge progress from one good morning.

Sources

1. The OARSI non-surgical management guideline evaluated 60 interventions with GRADE methodology and built its recommendations around core treatments - structured exercise, weight management and self-management education - for every patient with knee osteoarthritis, regardless of what else is added.

   Bannuru RR, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

2. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.

3. A 2025 meta-analysis of 73 double-blind placebo-controlled injection trials in 5,895 knee osteoarthritis patients found placebo responder rates above 50 percent at 1, 3 and 6 months, declining by 12 months - which is why any uncontrolled 'our patients improved' claim from a clinic is uninterpretable.

   Previtali D, et al. — Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression. EFORT Open Rev, 2025. DOI: 10.1530/EOR-2025-0022.

4. A meta-analysis of 14 placebo cohorts across 13 Level I trials in 1,076 knee osteoarthritis patients found that intra-articular saline - the placebo - produced pain and function improvements exceeding the minimal clinically important difference at 3 and 6 months.

   Saltzman BM, et al. — The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies. Am J Sports Med, 2017. DOI: 10.1177/0363546516680607.

5. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.